Sionna Therapeutics, Inc. SION 深 沪
等待开盘 09-17 09:30:00 美东时间
23.27
+0.960
+4.30%
华盛通- 最 高23.79
- 今 开22.14
- 成交量 16.90万股
- 最 低 21.735
- 昨 收 22.31
- 总市值 10.27亿
- 52周最高 26.50
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 7.255
- 委 比 -0.85%
- 总股本 4413.98万
- 历史最高 26.50
- 量 比 0.69
- 振 幅 9.21%
- 历史最低 7.255
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多西普尼，中国最大金表品牌，通过香港上市聆讯，莆田国资持股20%
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 2025年9月15日，来自深圳罗湖区的深圳西普尼精密科技股份有限公司S...
09-16 14:03
NAGRAVISION and MediaTek Partner to Enhance Streaming Security
An update from Kudelski SA ( ($CH:KUD) ) is now available. NAGRAVISION and Medi...
09-12 13:33
NAGRAVISION Expands OneTV Solution with Bango Integration for ONE Hungary
Kudelski SA ( ($CH:KUD) ) has provided an announcement. NAGRAVISION has expande...
09-11 00:04
美股大行评级 | Bernstein：首予Bullish"与大市齐平"评级，目标价60美元
今日重点评级关注：TD Cowen：上调加拿大鹅评级至"买入"，目标价从16美元升至18美元；Vertical Research：上调波音评级至"买入"，目标价从242美元升至270美元
09-09 09:58
CoinShares to Go Public in the U.S. Through US$1.2 Billion Business Combination
The leading European asset manager specializing in digital assets with ~US$10 billion in AuM sets sights on expanding into U.S. market CoinShares ranks among the top four managers globally b...
09-08 20:00
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer
Sionna Therapeutics announced the appointment of Caroline Stark Beer as Chief Business Officer, recognizing her over 20 years of experience in life sciences. Caroline, previously CBO at Jnana Therapeutics and VP of Business Development at Alnylam Pharmaceuticals, will support Sionna's goal of developing innovative CFTR modulators for cystic fibrosis treatment. With a focus on patient-centric growth, Caroline aims to enhance Sionna's corporate dev...
09-08 12:00
美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
RBC Capital Initiates Coverage On Sionna Therapeutics with Sector Perform Rating, Announces Price Target of $22
RBC Capital analyst Brian Abrahams initiates coverage on Sionna Therapeutics (NASDAQ:SION) with a Sector Perform rating and announces Price Target of $22.
09-03 21:53
华兴资本医疗与生命科技行业周报【Vol.382】
来源：华兴资本 “华兴资本医疗与生命科技行业周报”定期发布，专注从资本角度解读一周数据，并提供最新行业观察。 医疗与生命科技是华兴资本多年来关注并深耕的领域，目...
09-01 08:30
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
BOSTON, Aug. 29, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today released the following notice: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION WEINING H...
08-30 04:05
